CPE

Commercial Litigation: Understanding and Calculating Lost Profit Damages

2023-05-21T22:23:06-04:00

Commercial litigation can be a complex and costly process. Stakes are often high especially when it comes to calculating lost profits. In the battle over lost profit damages, both sides must face the tough challenge of choosing which calculation methodologies, documentation, and expert evidence to use. Defendants will often try to push back, citing credible damages studies that often leave the opposition with little to no significant damages awards.

The ITC Section 337 Investigations: Trends, Development, and Issues

2022-12-28T02:46:35-05:00

Patent investigations brought under International Trade Commission (ITC) have seen an upward trend in recent years. Consequently, as several types of products and components are imported in the U.S., an increase in patent litigation is also expected – a scenario that may put a large number of U.S. companies and their consumers at risk.

Trends and Developments in Distressed Debt, Restructurings and Workouts: Best Practices to Avoid Risk Issues

2022-09-29T04:39:28-04:00

In today's ever-evolving market economy, proper financial planning and effective risk prevention practices for businesses have been more crucial than ever. With distressed debts becoming more rampant, workouts and restructuring measures should be given more focus. Furthermore, significant court rulings under Chapter 11 of the bankruptcy code must also be followed to avoid future litigation that could result in claw-backs and fraud claims.

Determining FRAND Royalties for Standard Essential Patents in 2020

2023-01-19T22:28:22-05:00

In order to prevent patent-licensing problems, standard-setting organizations (SSOs) have created fair, reasonable, and non-discriminatory (FRAND) terms to ensure that standard-essential patent (SEP) owners will get patent benefits without unfair bargaining. Earlier this year, as patent holders are generally free to charge the users of their patents, the developers of technical standards have agreed to license the former’s SEPs to manufacturers of standardized products at royalty rates that are fair, reasonable and non-discriminatory. 

Go to Top